Product image of Erlotinib Qritou (Erlotinib) supplied by GNH India

Erlotinib Qritou

Active Ingredient:
Erlotinib
Origin:
EU

Erlotinib Qritou (Erlotinib)

Erlotinib Qritou is an oral medication used for targeted therapy in certain types of cancer. This medication, manufactured by Teva B.V., is designed to inhibit specific proteins that contribute to cancer cell growth.

Manufacturer / TM Owner

Teva B.V

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Erlotinib Qritou is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It works by targeting and blocking the activity of certain proteins that are involved in the growth and spread of cancer cells. This medication is often prescribed as part of a comprehensive cancer treatment plan.

Side Effects

  • Common effects of Erlotinib Qritou may include skin rash, diarrhea, and fatigue. Some individuals may also experience appetite loss, nausea, and dry skin. These effects can vary in severity and may not affect everyone who takes the medication.

Precautions & Warnings

  • Erlotinib Qritou should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by your healthcare professional. This medication may interact with other drugs, so it is crucial to inform your healthcare provider about all medications you are taking.

Avoid Interactions

  • Erlotinib Qritou may interact with certain medications, including those that are metabolized by the liver. It is important to avoid taking this medication with strong CYP3A4 inhibitors or inducers, as they can affect the effectiveness of Erlotinib Qritou. Always consult your healthcare provider before starting any new medication.

Frequently Asked Questions

Erlotinib Qritou is used for the treatment of non-small cell lung cancer and pancreatic cancer by targeting specific proteins involved in cancer cell growth.

Erlotinib Qritou is taken orally, typically once daily. Follow the specific instructions provided by your healthcare professional for the best results.

Common side effects may include skin rash, diarrhea, fatigue, appetite loss, nausea, and dry skin.

Erlotinib Qritou may interact with other medications, so it is important to consult your healthcare provider before combining it with any other drugs.

Erlotinib Qritou is manufactured by Teva B.V.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Erlotinib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT